Timo Frömel
Impact in
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
Papers in
- Biochemistry 17
- Eicosanoids and Hypertension Pharmacology 17
-
- Angiogenesis and VEGF in Cancer 3
- Co-authors
- Ingrid Fleming (30 shared papers)Rüdiger Popp (13 shared papers)Beate Fißlthaler (5 shared papers)Jiong Hu (10 shared papers)Khader Awwad (6 shared papers)Stefanie Dimmeler (2 shared papers)Nina Zippel (3 shared papers)Heinrich Heide (3 shared papers)
- Journals
- Blood (3 papers)Circulation Research (2 papers)Prostaglandins & Other Lipid Mediators (2 papers)Cells (2 papers)Basic Research in Cardiology (2 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Timo Frömel
29 papers receiving 976 citations
Peers
Comparison fields: 5 of 87
- Biochemistry 285
- Cancer Research 338
- Endocrinology, Diabetes and Metabolism 146
- Molecular Biology 521
- Pharmacology 48
Countries citing papers authored by Timo Frömel
This map shows the geographic impact of Timo Frömel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Frömel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Frömel more than expected).
Fields of papers citing papers by Timo Frömel
This network shows the impact of papers produced by Timo Frömel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Frömel. The network helps show where Timo Frömel may publish in the future.
Co-authors
The 25 scholars most cited alongside Timo Frömel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 193 | |
| 2 | 2013 | 110 | |
| 3 | 2011 | 73 | |
| 4 | 2014 | 69 | |
| 5 | 2012 | 59 | |
| 6 | 2013 | 48 | |
| 7 | 2012 | 47 | |
| 8 | 2014 | 43 | |
| 9 | 2016 | 43 | |
| 10 | 2010 | 40 | |
| 11 | 2013 | 40 | |
| 12 | 2012 | 39 | |
| 13 | 2009 | 26 | |
| 14 | 2018 | 23 | |
| 15 | 2021 | 18 | |
| 16 | 2014 | 17 | |
| 17 | 2021 | 16 | |
| 18 | 2016 | 15 | |
| 19 | 2018 | 15 | |
| 20 | 2017 | 12 |
About Timo Frömel
Timo Frömel is a scholar working on Biochemistry, Molecular Biology, Cancer Research, Endocrinology, Diabetes and Metabolism and Pharmacology, having authored 30 papers that have together received 987 indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (17 papers), Cancer, Hypoxia, and Metabolism (8 papers), Hormonal Regulation and Hypertension (6 papers), Alcohol Consumption and Health Effects (4 papers), Inflammatory mediators and NSAID effects (4 papers), Fatty Acid Research and Health (3 papers), Angiogenesis and VEGF in Cancer (3 papers) and Nitric Oxide and Endothelin Effects (3 papers). The work is most often cited by research in Biochemistry (285 citations), Cancer Research (338 citations), Endocrinology, Diabetes and Metabolism (146 citations), Molecular Biology (521 citations) and Pharmacology (48 citations). Timo Frömel has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Ingrid Fleming, Rüdiger Popp, Beate Fißlthaler, Jiong Hu, Khader Awwad, Stefanie Dimmeler, Nina Zippel, Heinrich Heide, Amro Elgheznawy and Angelika Bonauer. Their work appears in journals such as Blood, Circulation Research, Prostaglandins & Other Lipid Mediators, Cells and Basic Research in Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.